racemetirosine has been researched along with Abnormalities, Drug-Induced in 1 studies
alpha-Methyltyrosine: An inhibitor of the enzyme TYROSINE 3-MONOOXYGENASE, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with PHEOCHROMOCYTOMA. (Martindale, The Extra Pharmacopoeia, 30th ed)
Abnormalities, Drug-Induced: Congenital abnormalities caused by medicinal substances or drugs of abuse given to or taken by the mother, or to which she is inadvertently exposed during the manufacture of such substances. The concept excludes abnormalities resulting from exposure to non-medicinal chemicals in the environment.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cameron, RH | 1 |
| Kolesari, GL | 1 |
| Kalbfleisch, JH | 1 |
1 other study available for racemetirosine and Abnormalities, Drug-Induced
| Article | Year |
|---|---|
Pharmacology of dextroamphetamine-induced cardiovascular malformations in the chick embryo.
Topics: Abnormalities, Drug-Induced; alpha-Methyltyrosine; Animals; Chick Embryo; Dextroamphetamine; Heart D | 1983 |